ArticleHaematologica2023

Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established highrisk factors.

Anna Sandström Gerdtsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.